Atrium Ljungberg AB (publ) (ATRLJ-B)
Stockholm Exchange · Sweden · prices in SEK · close of 22 Oct 2026
Key indicators
| Last close | SEK 21.20 |
|---|---|
| 52-week range | 20.15 – 36.22 |
| Return, 1 month / 3 months | −15.4% / −20.0% |
| Return, 1 year / 3 years | −39.3% / −33.6% |
| Trend | Below its 200-day average |
| RSI (14) | 33 |
| Volatility (1 year) | 27.0% |
| Worst drawdown (1 year) | -41.3% |
| Average daily value traded | 15.02M SEK |
| Dividend yield | 3.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Atrium Ljungberg AB is a Swedish property company based in Stockholm that owns, develops and manages commercial real estate. Its portfolio centres on office, retail and mixed-use properties, often in urban development areas where it creates entire neighbourhoods combining workplaces, shops, services and public spaces. The company works with tenants ranging from businesses and retailers to public organisations, and it also takes on long-term development projects that reshape districts in and around Stockholm and other Swedish cities.
The shares are listed on the Stockholm Exchange in Sweden under the code ATRLJ-B, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Atrium Ljungberg AB (publ) (ATRLJ-B) trades on the Stockholm Exchange in Sweden. It last closed at SEK 21.20 on 22 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 505 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 39.3% and over the last three months it fell 20.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 25 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -24.9% | ||
| From 52-week high | -41.2% | ||
| Momentum | 23 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -20.0% | ||
| 6-month return | -30.8% | ||
| 12-month return, skipping the last month | -28.3% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.3% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 15.02M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.5% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −15.4% |
| 3 months | −20.0% |
| 6 months | −30.8% |
| 1 year | −39.3% |
| 3 years | −33.6% |
| 5 years | −39.8% |
Signals
| 50-day / 200-day average | 24.03 / 28.22 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.57 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Mar 2026 | SEK 0.7400 |
| 25 Sep 2025 | SEK 0.3600 |
| 21 Mar 2025 | SEK 1.8000 |
| 26 Sep 2024 | SEK 1.7500 |
| 22 Mar 2024 | SEK 1.7500 |
| 28 Sep 2023 | SEK 2.6500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.